Trial Profile
Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Were Treated With H.P. Acthar Gel After an Incomplete Response to Combinations of DMARDs and Biologic DMRADs
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 21 Mar 2017 New trial record